CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Intrexon Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Intrexon Corporation
222 Lakeview Avenue
Suite 1400
Phone: (858) 349-3617p:858 349-3617 W Palm Beach, FL  33401  United States Ticker: MEDS MEDS
This company was Merged or Acquired on 3/7/2014.
This company ceased filing statements with the SEC on 3/7/2014.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Medistem Inc. (Medistem), formerly Medistem Laboratories, Inc., is an adult stem cell biotechnology company that discovers, develops, and commercializes adult stem cell products that address serious medical conditions. The Company's primary focus is entry to clinical trials of its universal donor stem cell, the Endometrial Regenerative Cell (ERC), with its initial product candidates aimed at the treatment of critical limb ischemia and ischemic heart disease. In March 2013, Intrexon Corp acquired Medistem, Inc.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/200812/31/2007YesYes---

Industries
SIC Code Description
5812 Eating places
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President Neil H.Riordan 53 3/18/2008 10/1/2005
Chief Executive Officer IchimThomas 3/18/2008 3/18/2008
Chief Financial Officer Steven M.Rivers 41 7/3/2006 7/3/2006
5 additional Officers and Directors records available in full report.

Business Names
Business Name
Medistem Inc.
Medistem Laboratories, Inc.
MEDS
SGC HOLDINGS INC
SGC Holdings Inc.

General Information
Number of Employees: 4 (As of 12/31/2007)
Outstanding Shares: 4,920,833 (As of 11/1/2008)
Shareholders: 70
Stock Exchange: OTC
Federal Tax Id: 861047317
Fax Number: (858) 642-0027


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023